Cargando…

Design, Synthesis, and Molecular Docking Studies of Some New Quinoxaline Derivatives as EGFR Targeting Agents

The synthesis of some new quinoxaline derivatives (IVa–n) and their structure determination using (1)H NMR, (13)C NMR and mass spectral analysis was described herein. The in vitro anti-cancer activity of the these compounds (IVa–n) revealed that the compound1-((1-(4-bromophenyl)-1H-1,2,3-triazol-4-y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badithapuram, Vinitha, Nukala, Satheesh Kumar, Thirukovela, Narasimha Swamy, Dasari, Gouthami, Manchal, Ravinder, Bandari, Srinivas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pleiades Publishing 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212206/ https://www.ncbi.nlm.nih.gov/pubmed/35757285 http://dx.doi.org/10.1134/S1068162022030220

Ejemplares similares

Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents
por: Ahmed, Eman A., et al.
Publicado: (2022)

Synthesis and Antimicrobial Activity of Some New Quinoxaline Derivatives
por: Singh, Dharmchand Prasad, et al.
Publicado: (2010)

Synthesis and Antimicrobial Activity of Some New Substituted Quinoxalines
por: El-Atawy, Mohamed A., et al.
Publicado: (2019)

Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study
por: Almandil, Noor Barak, et al.
Publicado: (2019)

Synthesis, Characterization and Biological Evaluation of Some Quinoxaline Derivatives: A Promising and Potent New Class of Antitumor and Antimicrobial Agents
por: Al-Marhabi, Aisha R., et al.
Publicado: (2015)

Synthesis and Neuropharmacological Evaluation of Some Novel Quinoxaline 2, 3-Dione Derivatives
por: Jubie, Selvaraj, et al.
Publicado: (2012)

Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers
por: El Newahie, Aliya M. S., et al.
Publicado: (2019)

Synthesis, Antifungal Activities, Molecular Docking and Molecular Dynamic Studies of Novel Quinoxaline-Triazole Compounds
por: Osmaniye, Derya, et al.
Publicado: (2023)

Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-a]quinoxaline Derivatives as Novel Anticonvulsant Agents
por: Alswah, Mohamed, et al.
Publicado: (2013)

Synthesis and Evaluation of New Quinoxaline Derivatives of Dehydroabietic Acid as Potential Antitumor Agents
por: Gu, Wen, et al.
Publicado: (2017)

Chemically modified tetracyclines: The novel host modulating agents
por: Swamy, Devulapalli Narasimha, et al.
Publicado: (2015)

Synthesis, Molecular Docking and Biological Evaluation of Glycyrrhizin Analogs as Anticancer Agents Targeting EGFR
por: Yang, Yong-An, et al.
Publicado: (2014)

Synthesis and hypoglycemic activity of quinoxaline derivatives
por: Jia, Weidong, et al.
Publicado: (2023)

Green Design, Synthesis, and Molecular Docking Study of Novel Quinoxaline Derivatives with Insecticidal Potential against Aphis craccivora
por: Alanazi, Mariam Azzam, et al.
Publicado: (2022)

Synthesis, Biological Evaluation and Docking Analysis of Some Novel Quinazolin Derivatives as Antitumor Agents
por: El-serwy, Walaa S., et al.
Publicado: (2016)

New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents
por: Peraman, Ramalingam, et al.
Publicado: (2016)

Quinoxaline Derivatives as Antiviral Agents: A Systematic Review
por: Montana, Marc, et al.
Publicado: (2020)

Synthesis and Properties of Quinoxaline-Containing Benzoxazines and Polybenzoxazines
por: Chen, Chien Han, et al.
Publicado: (2019)

Synthesis of novel antibacterial and antifungal quinoxaline derivatives
por: Tang, Xuemei, et al.
Publicado: (2022)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
por: El-Sayed, Magda A.-A., et al.
Publicado: (2017)

Microwave-assisted synthesis, molecular docking studies of 1,2,3-triazole-based carbazole derivatives as antimicrobial, antioxidant and anticancer agents
por: Ashok, Dongamanti, et al.
Publicado: (2022)

Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment
por: Kumar, Manvendra, et al.
Publicado: (2021)

Design, efficient synthesis and molecular docking of some novel thiazolyl-pyrazole derivatives as anticancer agents
por: Sayed, Abdelwahed R., et al.
Publicado: (2019)

New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies
por: Alanazi, Mohammed M., et al.
Publicado: (2021)

Synthesis, Biological Evaluation and Structure-Activity Relationships of New Quinoxaline Derivatives as Anti-Plasmodium falciparum Agents
por: Gil, Ana, et al.
Publicado: (2014)

Gold-catalyzed oxidation of arylallenes: Synthesis of quinoxalines and benzimidazoles
por: Cui, Dong-Mei, et al.
Publicado: (2011)

Synthesis, Characterization and Protonation Behavior of Quinoxaline-Fused Porphycenes
por: Kuzuhara, Daiki, et al.
Publicado: (2017)

Recent advances in the transition-metal-free synthesis of quinoxalines
por: Borah, Biplob, et al.
Publicado: (2021)

Design, Synthesis, Molecular Docking, and Antibacterial Evaluation of Some Novel Flouroquinolone Derivatives as Potent Antibacterial Agent
por: Patel, Mehul M., et al.
Publicado: (2014)

Design, synthesis, and molecular docking studies of novel pomalidomide-based PROTACs as potential anti-cancer agents targeting EGFR(WT) and EGFR(T790M)
por: O. Aboelez, Moustafa, et al.
Publicado: (2022)

Design, Synthesis and Pharmacological Evaluation of Novel C(2),C(3)-Quinoxaline Derivatives as Promising Anxiolytic Agents
por: Maltsev, Dmitriy V., et al.
Publicado: (2022)

Synthesis and Characterization of Some New Quinoxalin-2(1H)one and 2-Methyl-3H-quinazolin-4-one Derivatives Targeting the Onset and Progression of CRC with SAR, Molecular Docking, and ADMET Analyses
por: El-Sayed, Nahed N. E., et al.
Publicado: (2021)

Synthesis, DNA-Binding, Anticancer Evaluation, and Molecular Docking Studies of Bishomoleptic and Trisheteroleptic Ru-Diimine Complexes Bearing 2-(2-Pyridyl)-quinoxaline
por: Balou, Sofia, et al.
Publicado: (2021)

Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
por: Alswah, Mohamed, et al.
Publicado: (2017)

Sequential Synthesis, Olfactory Properties, and Biological Activity of Quinoxaline Derivatives
por: Imanishi, Mia, et al.
Publicado: (2017)

An Efficient and Recyclable Nanoparticle-Supported Cobalt Catalyst for Quinoxaline Synthesis
por: Rajabi, Fatemeh, et al.
Publicado: (2015)

Reusable nano-catalyzed green protocols for the synthesis of quinoxalines: an overview
por: Keri, Rangappa S., et al.
Publicado: (2023)

Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies
por: Altamimi, Abdulmalik S., et al.
Publicado: (2021)

Quinoxaline-2-carbonitrile
por: Fun, Hoong-Kun, et al.
Publicado: (2009)

2-Chloroquinoxaline
por: Ng, Seik Weng
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_puo79l6ueo3d3sfd37f4in8pp3